Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Avanir and Concert Pharmaceuticals to develop deuterium-modified dextromethorphan

March 1, 2012

Global rights to biocrea phosphodiesterase program transferred

March 1, 2012

Johns Hopkins and ImmunoCellular Therapeutics enter licensing agreement for cancer antigen

March 1, 2012

Shire and arGEN-X to develop therapeutic antibodies for rare diseases

March 1, 2012

BMS and Duke Translational Medicine Institute broaden their collaboration

March 1, 2012

Abbott enters global agreement for novel JAK1 inhibitor

Feb. 29, 2012

Samsung Biologics and Biogen Idec form joint venture

Feb. 29, 2012

Lundbeck acquires remaining rights to ischemic stroke treatment candidate

Feb. 29, 2012

Antisense Therapeutics to form joint venture for development of ATL-1102

Feb. 29, 2012

Selventa enters new collaboration

Feb. 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...